QinetiQ Group (LON:QQ – Get Free Report) had its price objective reduced by analysts at JPMorgan Chase & Co. from GBX 420 ($5.16) to GBX 390 ($4.79) in a report issued on Monday, Digital Look reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 21.12% from the stock’s previous close.
Several other equities analysts have also weighed in on the company. Barclays reaffirmed an “overweight” rating and issued a GBX 465 ($5.71) price objective on shares of QinetiQ Group in a research note on Friday. Shore Capital reaffirmed a “buy” rating on shares of QinetiQ Group in a research report on Thursday. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 450 ($5.53) price objective on shares of QinetiQ Group in a research report on Thursday. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of GBX 444.40 ($5.46).
QinetiQ Group Trading Up 0.4 %
About QinetiQ Group
QinetiQ Group plc operates as a science and engineering company primarily in the defense, security, and infrastructure markets in the United Kingdom, the United States, Australia, Europe, and internationally. The company operates through EMEA Services and Global Products segments. It offers advanced materials and manufacturing products; artificial intelligence, analytics, and advanced computing technologies; cyber and electromagnetic technologies; human protection and performance systems; novel systems, and weapons and effects; platform and system design and assessment products; power sources, and energy storage and distribution products; robotics and autonomy services; secure communications and navigation systems; and sensing, processing, and data fusion systems.
- Five stocks we like better than QinetiQ Group
- Investing in Blue-Chip Stocks
- The most upgraded stocks in November have two things in common
- The How and Why of Investing in Biotech Stocks
- Monday.com rocked earnings like it’s the weekend
- CD Calculator: Certificate of Deposit Calculator
- Plan to own one retailer? Make it this one
Receive News & Ratings for QinetiQ Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QinetiQ Group and related companies with MarketBeat.com's FREE daily email newsletter.